DETROIT, Michigan (CBS DETROIT) – Henry Ford Health System is Michigan’s only hospital formula decided as a phase 3 trial for the Modern mRNA-1273 Coronavirusy vaccine, The National Institutes of Health was announced Monday.
Henry Ford is recruiting volunteers on this randomized double-blind test to determine whether a two-dose vaccine prevents COVID-19 infection in others exposed to coronavirus. Approximately 90 fitness systems in the United States are operating competitively to recruit a total of 30,000 volunteers to participate in the Modern Vaccine exam. The exam will be closer to volunteers once 30,000 more people have logged in, so you must temporarily register for http://www.HenryFord.com/ModernaVaccine.
“Henry Ford Health System is proud to be a component of the fight against this deadly virus,” said Adnan Munkarah, executive vice president and chief clinical officer of Henry Ford Health System. “As one of the region’s leading educational medical centers with more than $100 million in annual funding, Henry Ford is involved in many COVID-19 efforts with components around the world.”
The first two stages of the study, involving more than six hundred participants, revealed that the vaccine was safe. Phase 2 showed that the vaccine prompted the framework to produce antibodies; Phase 3 will determine whether this immune reaction is sufficient to neutralize the virus.
“Our most productive hope of controlling COVID-19 is with a vaccine,” said Dr. Marcus Zervos, Chief infectious diseases division of the Henry Ford Health System. “The Modern Vaccine looks very promising. In the initial studies that have been conducted so far, it appears and has produced protective antibodies at the point of an herbal infection.”
Typical vaccines that oppose viruses are made from a weakened or inactive virus, however, the mNR-1273 vaccine is not made with SARS-CoV-2. It is made of messenger ribonucleic acid (mRN), a genetic code that tells cells how to produce proteins. In this case, protein is a small component of the virus that is intended to help the body’s immune formula produce antibodies to fight the virus. However, it is possible that other people are still inflamed with SARS-CoV-2 in their activities, despite injections in the study.
All test participants will have a 50% chance of receiving the test vaccine or a placebo, a sterile saline solution that does not have an active vaccine. Anyone 18 years of age or older who is not immunosuppressed or pregnant or contemplating becoming pregnant would possibly volunteer for the test, provided that they have not won COVID-19 or any other vaccine or treatment. Researchers are interested in hiring:
Interested Americans can volunteer by completing the registration form on the website. MEMBERS of the COVE exam team will touch and plan two initial visits to the registration site. Currently, registration sites will be in Detroit at the Henry Ford Hospital Emergency Department (with a separate entrance), the new Center One construction (seventh floor) and the HAP construction (which houses the Employees Health Clinic) across the street. main hospital.
After two plans that are about a month apart, volunteers will scale at their registration site five more times and communicate to examine coordinators approximately 24 times over two years. During this time, players will be closely monitored through the COVID-19 symptom test team and will be evaluated to see if they have produced the antibodies to protect them from coronavirus. If a player is diagnosed with COVID-19 during their time on the test, the test team will provide the highest point of care.
“The physical condition and protection of each player is our most sensitive priority,” Dr. Munkarah said. “Your participation in this trial can help if the vaccine can save lives.”
Interested participants can volunteer to register or receive more information about the vaccine trial by visiting www.henryford.com/ModernaVaccine.
© 2020 CBS Broadcasting Inc. All rights reserved. These curtains may be published, disseminated, rewritten or distributed.